4.2 Article

The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients

Journal

SURGICAL INNOVATION
Volume 25, Issue 2, Pages 99-104

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/1553350617751461

Keywords

mismatch repair genes; surgery; molecular; stomach cancer

Categories

Funding

  1. Istituto Toscano Tumori (ITT) [ITT-2007]
  2. European Union [316929]
  3. Royal Marsden/Institute of Cancer Research National Institute for Cancer Research Biomedical Research Centre (RM/ICR NIHR BRC)

Ask authors/readers for more resources

Purpose. A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrectomy. Microsatellite instability (MSI-H) gastric cancer has been identified as a subgroup of gastric cancer that may be associated with an improved prognosis. The aim of the study was an analysis of MSI status on patients with margin involvement after gastrectomy and examination of the association between MSI, margin status, and survival outcomes. Methods. From a large prospectively annotated surgical database we collected clinicopathological and survival data on patients who had undergone a potentially curative resection for gastric cancer. MSI status was assessed using a standard 5-marker quasi-monomorphic mononucleotide repeat panel. Patients who were R+ and either microsatellite stable (MSS) or MSI-H were identified and clinicopathological characteristics and disease specific survival was compared. Results. Three hundred and eighty-six patients were identified; 102 (26.4%) cancers were MSI-H. The proportion of R+ resections was not significantly different in MSS and MSI-H groups. For MSS patients 3-, 5-, and 10-year disease-specific survival rates were 9.1%, 0%, and 0%, respectively; for patients with MSI-H R+ tumors these were 38.5%, 30.8%, and 15.4%, respectively. In Cox analysis MSI-H, female gender, and T >= 3 were significantly associated with survival. Conclusions. Patients with MSI-H gastric cancer may have long-term survival despite R+ margin status. The molecular division of gastric cancer may be an important step in identifying possible tailored surgical treatments corresponding to clinical and pathological factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available